Evidence map›Paper›PMID 39725703›Full record

ArticleCommunications medicine2024

Predicting sepsis mortality into an era of pandrug-resistant E. coli through modeling.

Benjamin J Koch, Daniel E Park, Bruce A Hungate, Cindy M Liu, James R Johnson, Lance B Price

Abstract read
In one paragraph

Article in Communications medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Benjamin J KochCenter for Ecosystem Science and Society, Northern Arizona University, Flagstaff, AZ, USA. ben.koch@nau.edu.ORCID http://orcid.org/0000-0002-1914-7681
Daniel E ParkDepartment of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.ORCID http://orcid.org/0000-0001-5139-5397
Bruce A HungateCenter for Ecosystem Science and Society, Northern Arizona University, Flagstaff, AZ, USA.ORCID http://orcid.org/0000-0002-7337-1887
Cindy M LiuDepartment of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.ORCID http://orcid.org/0000-0003-4537-173X
James R JohnsonMinneapolis Veterans Affairs Health Care System, Minneapolis, MN, USA.
Lance B PriceDepartment of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, DC, USA.

Funding

Northern Arizona University (NAU) Technology Research Initiative FundU.S. Department of Veterans Affairs (Department of Veterans Affairs) Office of Research and DevelopmentWellcome Trust
6 · The paper itself

Abstract

backgroundInfections caused by antibiotic-resistant bacteria are increasingly frequent, burdening healthcare systems worldwide. As pathogens acquire resistance to all known antibiotics - i.e., become pan-resistant - treatment of the associated infections will become exceedingly difficult. We hypothesized that the emergence of pan-resistant bacterial pathogens will result in a sharp increase in human mortality.

methodsWe tested this hypothesis by modeling the impact of a single hypothetical pan-resistant Escherichia coli strain on sepsis deaths in the United States. We used long-term data on sepsis incidence, mortality rates, strain dynamics, and treatment outcomes to parameterize a set of models encompassing a range of plausible future scenarios. All models accounted for historical and projected temporal changes in population size and age distribution.

resultsThe models suggest that sepsis deaths could increase 18- to 46-fold within 5 years of the emergence of a single pan-resistant E. coli strain. This large and rapid change contrasts sharply with the current expectation of gradual change under continuing multidrug-resistance.

conclusionsFailure to prevent the emergence of pan-resistance would have dire consequences for public health.

Identifiers

PMID39725703
PMCPMC11671531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.